What is LB Pharmaceuticals Inc Common Stock's share price today?
LB Pharmaceuticals Inc Common Stock (LBRX) share price today is $42.02 as of November 7, 2026 at 2:29 AM IST. The stock touched a day high of $42.21 and a day low of $38.56.What exchange does LB Pharmaceuticals Inc Common Stock stock trade on, and under what ticker symbol?
LB Pharmaceuticals Inc Common Stock stock trades on NASDAQ under the ticker symbol LBRX.What is LB Pharmaceuticals Inc Common Stock's market capitalization?
LB Pharmaceuticals Inc Common Stock's market capitalization is $1.31B as of November 7, 2026 at 2:29 AM IST.What is LB Pharmaceuticals Inc Common Stock's price-to-earnings (P/E) ratio?
LB Pharmaceuticals Inc Common Stock's price-to-earnings (P/E) ratio is 408.5 as of November 6, 2026.What is LB Pharmaceuticals Inc Common Stock's price-to-book (P/B) ratio?
LB Pharmaceuticals Inc Common Stock's price-to-book (P/B) ratio is 3.79 as of November 6, 2026.Can Indian investors buy LB Pharmaceuticals Inc Common Stock shares?
Yes, You can buy LB Pharmaceuticals Inc Common Stock shares from India through Tickertape, via our partnership with ViewTrade IFSC under the IFSCA Global Access framework, subject to RBI’s Liberalised Remittance Scheme (LRS) limits.How can I invest in LB Pharmaceuticals Inc Common Stock shares from India?
Indian investors can buy LB Pharmaceuticals Inc Common Stock shares in three steps: 1. Search LB Pharmaceuticals Inc Common Stock on the Tickertape app and tap Invest. 2. Complete your one-time digital KYC. 3. Fund your account and buy from as low as $1 via fractional shares.How does USD-INR currency movement affect returns from LB Pharmaceuticals Inc Common Stock shares for Indian investors?
Since LB Pharmaceuticals Inc Common Stock trades in USD, an Indian investor's INR returns depend on both the stock's price movement and the USD-INR exchange rate. If the rupee depreciates against the dollar, INR returns are boosted beyond the stock's USD return; if the rupee appreciates, INR returns are reduced.What is the minimum amount required to invest in LB Pharmaceuticals Inc Common Stock shares via Tickertape?
Indian investors can start investing in LB Pharmaceuticals Inc Common Stock (LBRX) shares from as little as $1 through fractional ownership on Tickertape - for example, $10 buys approximately 0.2379 shares at the current price of $42.02.
$
₹
$42.0210.33% (+3.93)
High
—
—
Low
—
—
Returns
—
—
1D
1W
1M
3M
6M
1Y
3Y
5Y
Max
Key Metrics
Key Metrics
PE TTM
PE TTM
Close price divided by the earnings per share for the trailing twelve months
408.5
PB
PB
Close price divided by the book value per share at the end of the most recent quarter
3.79
EPS TTM
EPS TTM
Net profit earned per share over the trailing twelve months (sum of the last 4 quarters)
$0.1
PEG Ratio
PEG Ratio
Price-to-Earnings (P/E) ratio divided by the forecasted annual earnings per share (EPS) growth rate over the next five years
—
Profit Margin
Profit Margin
Net profit divided by the total revenue for the most recent financial year
0%
Dividend Yield
Dividend Yield
Annual dividend per share for the trailing twelve months divided by the close price
—
Based on 11 analysts reports
Buy10 analysts
Hold1 analyst
Sell0 analyst
Price Upside
+38.06%
Earnings Growth
-124.48%
Rev. Growth
—
Company Profile
Company Profile
P/E Ratio
45.74
45.74
1Y Return
44.64%
44.64%
Buy Reco %
83.87
83.87
P/E Ratio
41.93
41.93
1Y Return
48.67%
48.67%
Buy Reco %
69.56
69.56
P/E Ratio
151.87
151.87
1Y Return
71.05%
71.05%
Buy Reco %
67.85
67.85
P/E Ratio
31.48
31.48
1Y Return
28.42%
28.42%
Buy Reco %
41.66
41.66
P/E Ratio
26.73
26.73
1Y Return
10.56%
10.56%
Buy Reco %
75.00
75.00
Forecast
Forecast
Price
Revenue
Earnings
Price Forecast
Price Forecast
2026
Current$42.01Baseline
Analyst Target - 1 year
Target$58+38.06%
All values in $
2026
Current$42.01Baseline
Analyst Target - 1 year
Target$58+38.06%
All values in $
Earnings Per Share Forecast
Earnings Per Share Forecast
2025
Current$-2.5Baseline
Forecast for Dec 2026
High$-4.63-85.2%
Average$-5.61-124.48%
Low$-6.85-174%
All values in $
2025
Current$-2.5Baseline
Forecast for Dec 2026
High$-4.63-85.2%
Average$-5.61-124.48%
Low$-6.85-174%
All values in $
Financials
Financials
Income
Balance Sheet
Cash Flow
Quarterly Normal View
Q3 2025
Q4 2025
Q1 2026
Q2 2026
Revenue
Net Income
| Financial Year | Q1 2024 | Q2 2024 | Q3 2024 | Q4 2024 | Q1 2025 | Q2 2025 | Q3 2025 | Q4 2025 | Q1 2026 | Q2 2026 |
|---|---|---|---|---|---|---|---|---|---|---|
| Total Revenue | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Gross Profit | - | - | -0 | - | - | - | -0.08 | -0.08 | -0.08 | -0.09 |
| Net Income | -16.15 | -27.69 | -14.18 | -5.07 | -5.08 | -5.08 | -3.55 | -11.47 | -19.05 | -51.60 |
| Net Profit Margin | - | - | - | - | - | - | - | - | - | - |
Peers
Peers & Comparison
Peers & Comparison
Comparing 2 stocks from
HealthcareBiotechnology
HealthcareBiotechnology
Valuation
Returns
Forecast
| Stock | PE TTMPE TTM | PBPB | PEG RatioPEG Ratio |
|---|---|---|---|
| LB Pharmaceuticals Inc Common Stock | 408.5 | 3.79 | - |
| Eli Lilly and Company | 45.74 | 31.17 | 1.32 |
| Johnson & Johnson | 41.93 | 7.85 | 2.99 |
Price Comparison
Price Comparison
Compare LBRX with any stock or ETFCompare LBRX with any stock or ETF
Comparing from
LBRX
LLY
JNJ